Kumoh National Institute of Technology Develops Blockchain-Based Medical Data Utilization Technology

Joint Business Agreement Signed Between University, Corporations, and Medical Research Institute
Collaboration on Developing AI-based Medical Data Utilization Technology Using Digital Twins

Kumoh National Institute of Technology (President Kim Sangho) is taking the lead in enabling the safe utilization and standardization of medical data through artificial intelligence, based on digital twin and blockchain technologies.

On May 20, the ICT Convergence Specialization Research Center at Kumoh National Institute of Technology signed a business agreement for the "Development of Medical Data Utilization Technology Using Digital Twin" with Rasellic Co., Ltd., Rasellic Institute for Regenerative Medicine, Pure Global Co., Ltd., and NSLab Co., Ltd. at Cheongun Hall on the Kumoh National Institute of Technology campus.

Ceremony for Business Agreement on 'Development of Medical Data Utilization Technology Using Digital Twin'
Photo by Kumoh National Institute of Technology

Key representatives from each organization attended the signing ceremony, including Kim Dongsung, head of the ICT Convergence Specialization Research Center at Kumoh National Institute of Technology (who also serves as CEO of NSLab), Sun Junmin, CEO of Rasellic Co., Ltd., Jung Jonghwa, director of Rasellic Institute for Regenerative Medicine, and Ahn Chiyoung, CEO of Pure Global Co., Ltd.

After the agreement was signed, the parties exchanged views on future directions for cooperation.

The five organizations will collaborate in the following areas: joint research and development of medical data utilization technology based on digital twins; integration of blockchain-based security and management technology for safe data preservation; standardization and interoperability of medical data; identification and execution of joint industry-academia research projects; cultivation of professionals and technology exchanges; and commercialization of research outcomes.

In particular, the participants plan to focus their resources on developing medical data technologies using digital twins in the fields of patient-tailored stem cell therapy and regenerative medicine.

Furthermore, by combining blockchain technology—which enables prevention of data tampering and supports distributed storage—they aim to thoroughly protect sensitive patient personal information and establish a robust infrastructure for secure data sharing among medical institutions.

Under this vision, the ICT Convergence Specialization Research Center at Kumoh National Institute of Technology will be responsible for technology development and validation, leveraging its core research capabilities in real-time digital twin, AI, IoT, and blockchain convergence technologies.

Rasellic Co., Ltd. will promote the development of customized medical services and stem cell therapy protocols linked to digital twin monitoring systems.

The Rasellic Institute for Regenerative Medicine is expected to provide tangible support for patient treatment by leveraging its expertise in the medical and bio data fields and utilizing the analyzed data.

In addition, Pure Global Co., Ltd., a global blockchain solution provider, plans to drive global commercialization within the healthcare industry.

Kim Dongsung, head of the ICT Convergence Specialization Research Center at Kumoh National Institute of Technology, stated, "We expect that advanced medical data utilization technology using digital twins will generate synergy for improving national health and driving innovation in medical services by being combined with robust blockchain security technology. We will actively cooperate to make this a model case for industry-academia collaboration that brings together the research capabilities of universities, the practical experience of companies, and the needs of the medical and industrial sectors."

Meanwhile, the ICT Convergence Specialization Research Center at Kumoh National Institute of Technology, led by Professor Kim Dongsung, has been fostering specialized research and talent in military-civilian ICT convergence technologies through the "Regional Intelligence Innovation Talent Development Project" by the Ministry of Science and ICT and the Institute for Information & Communications Technology Planning & Evaluation (IITP).

The combination of digital twin-based stem cell therapy technology and blockchain security is expected to drive innovation in patient-personalized advanced medical services and yield achievements in global commercialization.

This content was produced with the assistance of AI translation services.